Insider trading

Period: 120 months Stock: BMY + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

84 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

84 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

84 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

84 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
84 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
84 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

84 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
9 Sep 2026
Massacesi Cristian EVP,Chief Med Offr,Head of Dev
Sold at will
$403.50K 6,249 at 64.57
25.0%
Not planned
25 Aug 2026
Holzer Phil M SVP and Controller
Sold at will
$33.75K 500 at 67.50
2.9%
Not planned
1 Apr 2026
Elkins David V EVP, Chief Financial Officer
Sold at will 2×
$1.85M 30,000 at 61.67
15.9%
Not planned
2 Sep 2025
Elkins David V EVP, Chief Financial Officer
Sold at will
$2.65M 56,000 at 47.33
25.1%
Not planned
2 Aug 2025
Short Bartie Wendy EVP, Corporate Affairs
Sold at will
$16.72K 378 at 44.23
6.9%
Not planned
9 May 2025
Hickey Benjamin President, RayzeBio Org. · indirect
Sold at will
$3.70K 97 at 38.01
100%
Sold half or more
25 Apr 2025
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.
Bought
$202.22K 4,250 at 47.58
5.4%
Largest buy in 3 yrs
20 Feb 2025
BOERNER CHRISTOPHER S. Chief Executive Officer
Bought
$110.10K 2,000 at 55.05
1.9%
14 Feb 2025
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.
Bought
$100.00K 1,823 at 54.84
2.9%
4 Nov 2024
Holzer Phil M SVP and Controller
Sold at will
$38.93K 700 at 55.62
5.6%
Not planned
1 Nov 2024
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.
Bought
$100.06K 1,830 at 54.68
3.0%
First buy on file
5 Dec 2023
BOERNER CHRISTOPHER S. Chief Executive Officer
Bought
$99.56K 2,000 at 49.78
2.5%
28 Nov 2023
BOERNER CHRISTOPHER S. Chief Executive Officer
Bought
$150.05K 3,071 at 48.86
4.0%
First buy on file
20 Nov 2023
Bought
$423.39K 8,500 at 49.81
31.5%
First buy on file
24 Aug 2023
Powell Ann EVP, Chief Human Resources
Sold at will
$1.10M 17,986 at 61.25
39.2%
Not planned
3 Aug 2023
Plenge Robert M EVP, Chief Research Officer
Sold at will
$44.75K 732 at 61.14
10.0%
Not planned
3 May 2023
Vessey Rupert EVP & President, Research
Sold at will
$3.38M 50,385 at 67.06
51.3%
Sold half or more
6 Feb 2023
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$17.92M 240,000 at 74.65
50.4%
Sold half or more
6 Feb 2023
Powell Ann EVP, Chief Human Resources
Sold, plan not stated
$835.26K 11,183 at 74.69
32.7%
9 Nov 2022
Powell Ann EVP, Chief Human Resources
Sold, plan not stated
$1.31M 16,250 at 80.45
32.2%
7 Nov 2022
Vessey Rupert EVP, Research & Early Dev.
Sold, plan not stated
$3.62M 45,910 at 78.88
44.6%
20 Sep 2022
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$1.74M 25,000 at 69.71
5.0%
15 Sep 2022
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$3.59M 50,000 at 71.84
9.1%
14 Sep 2022
Powell Ann EVP, Chief Human Resources
Sold, plan not stated
$1.77M 25,000 at 70.75
33.1%
13 Sep 2022
Elkins David V EVP, Chief Financial Officer
Sold, plan not stated 2×
$9.55M 133,951 at 71.30
57.1%
Sold half or more
13 Jun 2022
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$2.22M 30,000 at 74.04
5.2%
6 Jun 2022
LEUNG SANDRA EVP, General Counsel
Sold, plan not stated
$4.87M 65,000 at 74.89
17.4%
21 Mar 2022
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$1.79M 25,000 at 71.52
4.1%
16 Mar 2022
Vessey Rupert EVP, Research & Early Dev.
Sold, plan not stated 2×
$5.16M 74,559 at 69.25
61.7%
Sold half or more
14 Mar 2022
BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer
Sold, plan not stated
$2.04M 29,532 at 69.20
41.3%
14 Mar 2022
Santiago Karen Murphy SVP & Controller
Sold, plan not stated
$455.10K 6,577 at 69.20
28.3%
24 Feb 2022
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$2.01M 30,000 at 67.00
6.2%
16 Dec 2021
Vessey Rupert EVP, Research & Early Dev.
Sold, plan not stated 2×
$1.20M 19,298 at 61.99
37.6%
24 Nov 2021
von Autenried Paul EVP, Chief Information Officer · indirect
Sold, plan not stated
$987.73K 17,353 at 56.92
21.5%
23 Nov 2021
von Autenried Paul EVP, Chief Information Officer · indirect
Sold, plan not stated
$886.07K 15,418 at 57.47
16.0%
22 Nov 2021
von Autenried Paul EVP, Chief Information Officer · indirect
Sold, plan not stated
$1.05M 18,363 at 57.17
16.0%
20 Sep 2021
Caforio Giovanni Board Chair and CEO
Sold, plan not stated
$1.52M 25,000 at 60.64
4.9%
12 Aug 2021
Elkins David V EVP, Chief Financial Officer
Sold, plan not stated 2×
$6.67M 99,691 at 66.95
58.9%
Sold half or more
3 Aug 2021
Powell Ann EVP, Chief Human Resources
Sold, plan not stated
$1.60M 23,280 at 68.57
32.8%
2 Aug 2021
Caforio Giovanni Chairman and CEO
Sold, plan not stated
$1.37M 20,000 at 68.58
3.8%
30 Jul 2021
Vessey Rupert EVP, Research & Early Dev.
Sold, plan not stated 2×
$10.78M 158,393 at 68.07
81.2%
Sold half or more
30 Jul 2021
LEUNG SANDRA EVP, General Counsel
Sold, plan not stated
$2.00M 29,390 at 68.04
8.0%
30 Jul 2021
von Autenried Paul EVP, Chief Information Officer
Sold, plan not stated
$1.70M 25,000 at 68.06
17.9%
30 Jul 2021
Dubow Adam SVP,ChiefCompliance&EthicsOff.
Sold, plan not stated
$167.44K 2,466 at 67.90
15.2%
10 May 2021
Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply
Sold, plan not stated
$978.75K 15,000 at 65.25
31.9%
10 May 2021
Eid Joseph SVP,Head Glob. Medical Affairs
Sold, plan not stated
$72.67K 1,118 at 65.00
12.2%
5 May 2021
Vessey Rupert EVP, Research & Early Dev.
Sold, plan not stated
$1.96M 30,546 at 64.29
40.4%
5 May 2021
Dubow Adam SVP,ChiefCompliance&EthicsOff.
Sold, plan not stated
$200.27K 3,119 at 64.21
16.1%
22 Mar 2021
Caforio Giovanni Chairman and CEO
Sold, plan not stated
$1.56M 25,000 at 62.20
4.5%
25 Nov 2020
von Autenried Paul EVP, Chief Information Officer
Sold, plan not stated
$190.50 3 at 63.50
0.0%
Showing 1–50 of 84. Page 1 of 2 Older →